Trials / Conditions / Stage IV Thyroid Gland Medullary Carcinoma AJCC v8
Stage IV Thyroid Gland Medullary Carcinoma AJCC v8
4 registered clinical trials studyying Stage IV Thyroid Gland Medullary Carcinoma AJCC v8 — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced NCT04514484 | National Cancer Institute (NCI) | Phase 1 |
| Active Not Recruiting | Cancer and Blood Pressure Management, CARISMA Study NCT04467021 | ECOG-ACRIN Cancer Research Group | N/A |
| Recruiting | Natural History of Medullary Thyroid Cancer to Inform Advanced Disease Management NCT04216732 | M.D. Anderson Cancer Center | — |
| Withdrawn | Radioactive Drug (177Lu-DOTATATE) for the Treatment of Locally Advanced, Metastatic, or Unresectable Rare Endo NCT04106843 | M.D. Anderson Cancer Center | Phase 2 |